U.S. markets closed

Quidel Corporation (QDEL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
103.45+3.85 (+3.87%)
At close: 04:00PM EDT
103.50 +0.05 (+0.05%)
After hours: 07:56PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close99.60
Bid103.00 x 1400
Ask112.00 x 800
Day's Range97.95 - 103.82
52 Week Range88.05 - 180.06
Avg. Volume516,903
Market Cap4.329B
Beta (5Y Monthly)0.02
PE Ratio (TTM)4.38
EPS (TTM)23.62
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est160.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
136% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for QDEL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Quidel Corporation
    QDEL: Raising target price to $109.00QUIDEL CORP has an Investment Rating of HOLD; a target price of $109.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    10 days agoArgus Research
View more
  • Business Wire

    QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics

    SAN DIEGO, May 27, 2022--QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho") announced completion of the transaction combining Quidel Corporation ("Quidel") and Ortho Clinical Diagnostics Holdings plc ("Ortho"), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated more than $3.5 billion in combined revenues in 2021 and has approximately 6,000 employees. QuidelOrtho will trade on the Nasdaq Global Select Market under t

  • GlobeNewswire

    Quidel and Ortho Announce Expected Closing of Ortho Transaction

    SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc (“Ortho”), one of the world’s larger pure-play in vitro diagnostics companies, announced today that the closing of the previously announced Ortho transaction is expected to occur on May 27, 2022. On May 26, 2022, the High Court of Justice of England a

  • Investopedia

    Top Healthcare Stocks for June 2022

    These are the healthcare stocks with the best value, fastest growth, and most momentum for June 2022.